Corey Goodman is the President of Pfizer's Biotherapeutics and Bioinnovation Center. He oversees this newly established entrepreneurial center which is focused on translating biomedical discoveries into new medicines. The center is both independent and interdependent on Pfizer Global Research and Development (PGRD), creating and overseeing a consortium of units and collaborations with the academic, biomedical, biotech and venture capital communities, while collaborating closely with PGRD. Corey joined Pfizer to head the Biotherapeutics and Bioinnovation Center in October 2007.

Born in Chicago, Corey attended Stanford University as a Searle Scholar and earned his B.S. in Biology with distinction and honors. He was an NSF Fellow at the University of California Berkeley and earned his Ph.D. in Neurobiology. He was then a Helen Hay Whitney Postdoctoral Fellow at U.C. San Diego.

He was a Professor at Stanford University and U.C. Berkeley for over two decades, and is currently Adjunct Professor at U.C. Berkeley. While on the faculty at Berkeley, Corey was an Investigator with the Howard Hughes Medical Institute, Evan Rauch Professor of Neuroscience, co-founder of the Wills Neuroscience Institute, and Head of the Division of Neurobiology.

Corey was elected a member of the U.S. National Academy of Sciences, a Fellow of the American Academy of Arts and Sciences, and a member of the American Philosophical Society. Among his many scientific honors are the Alan T. Waterman Award from the National Science Board, the Gairdner Foundation International Award for Achievement in Medical Sciences, the Wakeman Award, the March of Dimes Prize in Developmental Biology, and the Reeve-Irvine Research Medal.

Corey has advised numerous biotechnology companies, and co-founded two of them: Exelixis and Renovis. He served as the President and Chief Executive Officer of Renovis from 2001 until 2007 when the company's merger with Evotec was announced. Among his many public service roles, Corey is Vice President of the McKnight Endowment Fund for Neuroscience, a member of the California Council on Science and Technology, and a member of the boards of BayBio and the Bay Area Science and Innovation Consortium (BASIC). He is former Chair of the National Research Council's board on Life Sciences.